Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract Cancers (ABC-03)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00939848 |
Recruitment Status :
Completed
First Posted : July 15, 2009
Last Update Posted : October 27, 2014
|
Sponsor:
University College, London
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
University College, London
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | September 2012 |
Actual Study Completion Date : | September 2014 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):